Fulcrum Asset Management LLP lifted its stake in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 12,067.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,984 shares of the company’s stock after acquiring an additional 27,754 shares during the period. Fulcrum Asset Management LLP’s holdings in Bath & Body Works were worth $447,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Bath & Body Works in the second quarter valued at approximately $449,065,000. Bank of America Corp DE bought a new stake in Bath & Body Works during the second quarter worth approximately $62,249,000. Bank of New York Mellon Corp bought a new stake in Bath & Body Works during the second quarter worth approximately $59,260,000. Renaissance Technologies LLC lifted its position in Bath & Body Works by 885.7% in the first quarter. Renaissance Technologies LLC now owns 2,732,733 shares of the company’s stock worth $51,020,000 after purchasing an additional 2,455,500 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in Bath & Body Works in the second quarter worth approximately $46,706,000. 95.14% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
BBWI has been the subject of a number of research reports. BMO Capital Markets assumed coverage on Bath & Body Works in a research note on Tuesday, September 8th. They set a “market perform” rating and a $20.00 price target for the company. Argus restated a “hold” rating on shares of Bath & Body Works in a report on Wednesday, September 16th. Barclays cut their price objective on Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Thursday, August 27th. Wells Fargo & Company raised their target price on Bath & Body Works from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Thursday, October 29th. Finally, JPMorgan Chase & Co. lifted their target price on Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Four investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $22.53.
Check Out Our Latest Report on Bath & Body Works
Bath & Body Works Stock Performance
NYSE BBWI opened at $21.36 on Monday. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $24.94. The stock has a market cap of $4.31 billion, a price-to-earnings ratio of 5.56, a PEG ratio of 1.07 and a beta of 1.31. The firm’s 50 day moving average price is $19.21 and its two-hundred day moving average price is $19.82.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.38. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company’s revenue was down 2.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.30 EPS. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, research analysts forecast that Bath & Body Works, Inc. will post 2.74 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, November 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.7%. Bath & Body Works’s payout ratio is currently 20.83%.
Bath & Body Works Profile
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
